Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AbbVie Inc.
  6. Financials
    ABBV   US00287Y1091

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 138 674130 935189 171189 689--
Entreprise Value (EV)1 170 923157 739266 778256 082243 115232 932
P/E ratio 25,2x16,8x39,4x14,6x11,8x13,8x
Yield 4,28%4,96%4,52%4,77%5,15%5,27%
Capitalization / Revenue 4,24x3,94x4,13x3,37x3,18x3,37x
EV / Revenue 5,22x4,74x5,83x4,55x4,08x4,14x
EV / EBITDA 10,4x8,89x11,8x8,83x7,74x8,41x
Price to Book -16,9x-16,1x13,7x10,9x7,63x6,64x
Nbr of stocks (in thousands) 1 504 2161 478 8211 765 4741 767 176--
Reference price (USD) 92,288,5107107107107
Announcement Date 01/25/201902/07/202002/03/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 32 73333 26645 78456 24759 58956 310
EBITDA1 16 35817 74722 64229 01031 40427 713
Operating profit (EBIT)1 14 59315 73021 97628 05330 55426 879
Operating Margin 44,6%47,3%48,0%49,9%51,3%47,7%
Pre-Tax Profit (EBT)1 5 1978 4263 39814 12117 80615 974
Net income1 5 6877 8824 61612 65215 37013 299
Net margin 17,4%23,7%10,1%22,5%25,8%23,6%
EPS2 3,665,282,727,369,077,80
Dividend per Share2 3,954,394,845,125,535,66
Announcement Date 01/25/201902/07/202002/03/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 13 85812 93513 95914 32815 06513 892
EBITDA1 6 7226 8087 1457 2887 578-
Operating profit (EBIT)1 6 4956 6026 9447 1587 3246 838
Operating Margin 46,9%51,0%49,7%50,0%48,6%49,2%
Pre-Tax Profit (EBT) ------
Net income1 36,03 5537663 3813 5912 557
Net margin 0,26%27,5%5,49%23,6%23,8%18,4%
EPS2 0,011,990,422,002,141,43
Dividend per Share ------
Announcement Date 02/03/202104/30/202107/30/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 32 24926 80477 60766 39353 42643 243
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,97x1,51x3,43x2,29x1,70x1,56x
Free Cash Flow1 12 78912 77216 79018 84525 44923 146
ROE (Net Profit / Equities) --188%144%124%80,8%
Shareholders' equity1 --2 4528 77112 41316 453
ROA (Net Profit / Asset) 8,74%10,6%3,85%12,1%13,6%12,9%
Assets1 65 06974 234119 840104 274113 195103 177
Book Value Per Share2 -5,46-5,517,839,8114,116,2
Cash Flow per Share2 8,688,9810,510,214,613,7
Capex1 6385527989811 030955
Capex / Sales 1,95%1,66%1,74%1,74%1,73%1,70%
Announcement Date 01/25/201902/07/202002/03/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 189 688 621 604
Net sales (USD) 45 784 000 000
Number of employees 48 000
Sales / Employee (USD) 953 833
Free-Float 98,0%
Free-Float capitalization (USD) 185 875 119 385
Avg. Exchange 20 sessions (USD) 1 102 588 489
Average Daily Capital Traded 0,58%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA